“…Though there have been preceding studies on antimycotic induced PAFE's and its impact on numerous pathogenic attributes of Candida , mainly on C . albicans, the methodological differences between researchers, in addition to disparities in the concentrations of the drugs used, number and the types of Candida species betrothed, exposure time of the drug and the pathogenic attributes tested make comparisons arduous between the current study with previously studies. Nonetheless, to our knowledge the current study is the first to document the suppression of adhesion to BEC and the PAFE induced by antifungal agents that have a wide spectrum of pharmacodynamic properties (i.e.…”